StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ORMPORAMED PHARMACEUTICALS INC.
stockpulse.co.kr
Nasdaq
$4.13▼ 0.24%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $169.0MShares out 40.9M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

14
  • 10.2After-hours26.10.03 06:19
    4Ownership#●●●

    ORAMED PHARMACEUTICALS INC.

    Gabay Avraham, an officer of Oramed Pharmaceuticals Inc. (ORMP), filed a Form 4 regarding changes in beneficial ownership of securities effective October 1, 2026. This filing serves as a standard disclosure of insider equity transactions.…more

    $4.13-0.24%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.2After-hours26.10.03 06:19
    4Ownership

    ORAMED PHARMACEUTICALS INC.

    Oramed Pharmaceuticals (ORMP) executive Joshua Hexter reported an insider transaction dated October 1, 2026. This filing formalizes the change in the executive's beneficial ownership of securities via SEC Form 4.…more

    $4.13-0.24%vs prev close
    View filingShare
  • 10.1Pre-market26.10.01 20:43
    144Ownership

    ORAMED PHARMACEUTICALS INC.

    Gabay Avraham of Oramed Pharmaceuticals Inc. has filed SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the insider's intent to dispose of their equity holdings.…more

    $4.13-0.24%vs prev close
    View filingShare

13 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.